Cell and gene company makes major acquisition in Boston hub
Contract development and manufacturing organisation (CDMO) uBriGene is expanding into the US market with the acquisition of a manufacturing facility from Mustang Bio. The cell & gene therapy (CGT) CDMO has an established global footprint with two GMP manufacturing facilities in China and its headquarters in… Read More